SL
Insider
Sr One Capital Management, Llc
10% ownerSr One Capital Management, Llc (10% owner) filed 3 Form 4 reports as a reporting entity in the trailing twelve months (3 purchases, 0 sales), most often in AVLN. Across 3 priced purchase filings, the average 21-session return was +7.4% from execution and +11.3% from disclosure (delay-adjusted; derived). The largest single filing was $10.0M of ODTX (555,555 sh across 3 lots, as filed), executed May 11.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+7.4%
avg across 3 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+11.3%
same 3 filings, from disclosure
Filings, ttm
3
3 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$22.4M
shares × price, as filed
Last traded
May 11
Filed May 11
Volume by month
Buys $22.4M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Not on file
2 filings
Sector per market data · by filing · past 12 months
Most traded names
AVLN
AVLN
AVLN · 1 buy · 0 sells
1 filing
ODTX
ODTX
ODTX · 1 buy · 0 sells
1 filing
ZBIORecent filings
ODTXPURCHASE
Odyssey Therapeutics, Inc.
View filing →
$10.0M555,555 sh across 3 lots
Exec May 11
Filed May 11 · 9:11 PM ET AVLNPURCHASE Avalyn Pharma Inc. View filing → $10.0M
555,555 sh across 2 lots
Exec May 1
Filed May 1 · 6:46 PM ET ZBIOPURCHASE Zenas BioPharma, Inc. View filing → $2.4M
126,315 sh across 2 lots
Exec Oct 9 2025
Filed Oct 14 2025 · 5:14 PM ET ZBIOPURCHASE Zenas BioPharma, Inc. View filing → $38.0M
2,235,294 sh across 3 lots
Exec Sep 16 2024
Filed Sep 16 2024 · 5:30 PM ET